Status:

TERMINATED

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

Lead Sponsor:

Centro Medico ABC

Conditions:

Covid-19

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Open label two arms, non randomized Convalescent Plasma treatment to severe and critical pneumonia COVID-19 hospitlaized patients compared to a historical cohort with matched controls.

Detailed Description

We will perform an open label two arms, non randomized trial giving Convalescent Plasma donated from recovered COVID-19 patients with positive serology to severe and clinical pneumonia COVID-19 patien...

Eligibility Criteria

Inclusion

  • Donors:
  • Age: \>18 and \<60 years
  • Body weight : \>60 kg
  • Confirmed previous SARS CoV-2 infection
  • negative SARS CoV-2 test result
  • 21 day without symptoms from the negative SARS CoV2 negative test
  • Written informed consent to participate in this clinical trial, to donate plasma and to store the specimen for future testing.
  • Positive COVID-19 IgG antibodies
  • Male donors, or female donors who have not been pregnant, or female donors who have been pregnant tested negative for HLA antibodies
  • Individuals who meet all regular voluntary donor eligibility requirements by the Mexican legislation.
  • Patients/recipients:
  • Age: \>18 years
  • Admitted to the ABC Medical Center facility for the treatment of COVID-19
  • Patients with severe or critical COVID-19
  • Informed consent provided by the patient or healthcare proxy

Exclusion

  • Patients/recipients:
  • 1\. Contraindication to transfusion (severe volume overload, history of anaphylaxis to blood products) 2. Any other not controlled infection 3. Disseminated Intravascular Coagulopathy 4. Patient under dialysis 5. Patient with recent Hemorrhagic Stroke 6. Severe Ischemic Heart Disease
  • \-

Key Trial Info

Start Date :

August 8 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 29 2021

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT04432103

Start Date

August 8 2020

End Date

January 29 2021

Last Update

August 2 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centro Medico Abc

Mexico City, Mexico, 01120